JAK or TNF Inhibitor as First Drug for Rheumatoid Arthritis? A JAK inhibitor outperformed TNF blockers for substantially reducing RA symptoms in patients for whom conventional anti-rheumatic drugs had failed, a pragmatic head-to-head trial found. https://t.co/7BhFSwb1Ns https://t.co/Hf31OPgE0M

• JAK or TNF Inhibitor as First Drug for Rheumatoid Arthritis? | RheumNow